Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.25+0.68 (+4.10%)
At close: 04:00PM EDT
16.99 -0.26 (-1.51%)
After hours: 07:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/11/2022
Current
6/30/20223/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
2.33B1.64B1.30B2.13B3.65B3.69B
Enterprise Value
1.95B1.26B913.10M1.69B3.12B3.04B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
10.91k7.68k32.1551.8187.7385.81
Price/Book (mrq)
2.721.921.432.193.583.46
Enterprise Value/Revenue
7.89k14.62k14.97k33.21k63.62k69.17k
Enterprise Value/EBITDA
-6.63-17.24-11.97-24.31-41.38-44.07

Trading Information

Stock Price History

Beta (5Y Monthly) 0.55
52-Week Change 3-18.44%
S&P500 52-Week Change 3-4.45%
52 Week High 327.86
52 Week Low 36.43
50-Day Moving Average 312.19
200-Day Moving Average 312.03

Share Statistics

Avg Vol (3 month) 32.01M
Avg Vol (10 day) 31.93M
Shares Outstanding 5143.81M
Implied Shares Outstanding 6N/A
Float 881.9M
% Held by Insiders 129.89%
% Held by Institutions 167.03%
Shares Short (Jul 28, 2022) 422.4M
Short Ratio (Jul 28, 2022) 413.9
Short % of Float (Jul 28, 2022) 424.99%
Short % of Shares Outstanding (Jul 28, 2022) 415.60%
Shares Short (prior month Jun 29, 2022) 422.49M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-124,756.27%

Management Effectiveness

Return on Assets (ttm)-18.57%
Return on Equity (ttm)-33.71%

Income Statement

Revenue (ttm)247k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)95.50%
Gross Profit (ttm)-181.69M
EBITDA -294.21M
Net Income Avi to Common (ttm)-307.69M
Diluted EPS (ttm)-2.20
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)490.49M
Total Cash Per Share (mrq)3.41
Total Debt (mrq)103.58M
Total Debt/Equity (mrq)12.91
Current Ratio (mrq)11.42
Book Value Per Share (mrq)5.58

Cash Flow Statement

Operating Cash Flow (ttm)-205.08M
Levered Free Cash Flow (ttm)-109.27M
Advertisement
Advertisement